EC approval
Scope
Date
~
-
Bio & Pharma
Celltrion to seek FDA approval for sale of Remsima SC by year-end
Celltrion Inc. said it has confirmed the effectiveness and safety of Remsima SC in its third-phase global clinical trials, conducted on 438 patients...
Nov 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Mezzion Pharma to try again for US FDA approval of drug
South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...
Nov 23, 2022 (Gmt+09:00)
-
Petrochemicals
S-Oil to OK $6 billion Shaheen project as Saudi prince heads to Seoul
S-Oil Corp., the South Korean unit of Saudi Arabian Oil Co., will approve the much-touted 8 trillion won ($6 billion) Shaheen project to expand its ...
Nov 14, 2022 (Gmt+09:00)
-
Leadership & Management
Jay Y. Lee inaugurated as chairman of Samsung Electronics
Samsung Electronics Co.'s leader Jay Y. Lee was promoted as the company's chairman on Oct. 27.Samsung Electronics' board of directors approved the a...
Oct 27, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins sales approval for biosimilar Vegzelma in Japan
Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...
Sep 27, 2022 (Gmt+09:00)
-
Shareholder activism
Shareholder activism gathers momentum in South Korea
Institutional investors gathered momentum for shareholder activism in South Korea not only to boost their values but also to improve corporate gover...
Sep 19, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Precision Biosensor enters Italy with chemical test kits
South Korea’s diagnostic devices supplier Precision Biosensor Inc. has signed an export contract with Italian medical device company Borden Ch...
Sep 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion gains sales approval for biosimilar Vegzelma in Europe
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...
Aug 19, 2022 (Gmt+09:00)
-
COVID-19
Ildong mulls seeking COVID-19 pill approval from Korea first
Ildong Pharmaceutical Co., a South Korean drugmaker, considers seeking approval for a COVID-19 anti-viral pill from the country as Japan postponed g...
Jul 22, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience wins marketing license for Korea's first COVID-19 vaccine
South Korea’s SK Bioscience Co., a biopharmaceutical unit of SK Group, has won marketing authorization for its COVID-19 vaccine from the Minis...
Jun 29, 2022 (Gmt+09:00)
language -
Banking & Finance
Korea Woori Card to start installment finance biz in Indonesia
Woori Card Co. is set to start the installment finance business in Indonesia, Southeast Asia’s largest economy as the credit card unit of Sout...
Jun 27, 2022 (Gmt+09:00)
-
Bio & Pharma
Hugel accelerates European botox sales with Poland's approval
Hugel Inc., South Korea’s largest maker of botulinum toxin products used to treat overactive muscles and facial wrinkles, has won sales approv...
Jun 03, 2022 (Gmt+09:00)
-
Energy
S.Korea to bid for Saudi Arabia's $10 bn nuclear plant order
Saudi Arabia invited South Korea last week to join the bid for the construction of its first-ever nuclear power plants, worth over $10 billion, sour...
May 31, 2022 (Gmt+09:00)
language -
Mergers & Acquisitions
Korean Air vows to get nod from all antitrust bodies for Asiana merger
Korean Air Lines Co., which is putting the final touches on its acquisition of crosstown rival Asiana Airlines Inc., said on Monday it expects to ob...
May 23, 2022 (Gmt+09:00)
language -
Bio & Pharma
Daewoong's Nabota approved for sale in Saudi Arabia, Ukraine
South Korea’s Daewoong Pharmaceutical Co. has obtained approval for the sale of its botulinum toxin product, Nabota, in Saudi Arabia and Ukrai...
May 19, 2022 (Gmt+09:00)
-
Bio & Pharma
Medytox-Hugel dispute over botox strain intensifies with ITC probe
A legal dispute over a botox strain between South Korean pharmaceutical company Medytox Inc. and its crosstown rival Hugel Inc. has intensified with...
May 03, 2022 (Gmt+09:00)
-
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Mergers & Acquisitions
Korea approves Korean Air-Asiana merger; hurdles remain
The proposed merger of Korean Air Lines Co. and Asiana Airlines Inc. has moved one step closer to completion with approval by South Korea’s an...
Feb 22, 2022 (Gmt+09:00)
language -
Mergers & Acquisitions
Singapore approves Korean Air-Asiana combination
Singapore’s antitrust authority approved the integration of Korean Air Lines Co. and Asiana Airlines Inc., paving the way for South Korea&rsqu...
Feb 09, 2022 (Gmt+09:00)
-
Corporate restructuring
NPS approves POSCO's split into holding firm, steelmaker unit
The National Pension Service (NPS) of Korea, the largest shareholder of POSCO Co., has given its nod to the steelmaking giant’s plan to spli...
Jan 24, 2022 (Gmt+09:00)
-
Energy
Hylium, KRISO, POSCO receive initial approval for liquid hydrogen storage tanks
Hylium Industries Inc. announced Wednesday that it has been granted an approval in principle (AIP) by the Korean Register for two types of jointly d...
Jan 12, 2022 (Gmt+09:00)
-
Shipping & Shipbuilding
Hyundai Heavy uneasy ahead of EU decision despite $2.5 bn orders
South Korea’s Hyundai Heavy Industries Group grew more concerned ahead of the European Union’s decision on the combination of the world&...
Jan 11, 2022 (Gmt+09:00)
language -
Mergers & Acquisitions
Edison Motors and Ssangyong Motor ink takeover deal
Ssangyong Motor Co. has finally found a new owner. South Korea’s bankruptcy court approved Ssangyong Motor Co. and electric carmaker Edison Mo...
Jan 10, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Korean Air’s post-merger plan hits snag after conditional approval
Korean Air Lines Co. faces growing pressure from the country’s antitrust regulator to drastically adjust its post-merger integration plans aft...
Jan 04, 2022 (Gmt+09:00)
-
Pharmeceuticals
Kolon resumes Invossa phase 3 clinical trials in US
Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...
Dec 28, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
SK Hynix wins China’s approval for $9 billion Intel NAND acquisition
SK Hynix Inc. has received approval from China’s antitrust regulator for its $9 billion deal to acquire Intel Corp.’s NAND memory chip b...
Dec 23, 2021 (Gmt+09:00)
language -
COVID-19
Korea approves export of Samsung Biologics-made Moderna vaccine
South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...
Dec 14, 2021 (Gmt+09:00)
language -
Corporate restructuring
POSCO approves holding company plan for eco-friendly business
South Korea’s POSCO Co. is set to split off the company to launch an investment holding firm, 21 years after its privatization. The move aims ...
Dec 10, 2021 (Gmt+09:00)
language
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand